Cargando…

Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial

IMPORTANCE: An alternative option to maternal vaccination to prevent severe pertussis in infants is vaccination at birth. Data are needed on the immunogenicity and safety of a birth dose of monovalent acellular pertussis (aP) vaccine. OBJECTIVE: To compare IgG antibody responses to vaccine antigens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wood, Nicholas, Nolan, Terry, Marshall, Helen, Richmond, Peter, Gibbs, Emma, Perrett, Kirsten, McIntyre, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248137/ https://www.ncbi.nlm.nih.gov/pubmed/30208475 http://dx.doi.org/10.1001/jamapediatrics.2018.2349

Ejemplares similares

OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule
por: Perez Chacon, Gladymar, et al.
Publicado: (2020)

Association of Diphtheria-Tetanus–Acellular Pertussis Vaccine Timeliness and Number of Doses With Age-Specific Pertussis Risk in Infants and Young Children
por: Rane, Madhura S., et al.
Publicado: (2021)

Development and implementation of standardized method for detecting immunogenicity of acellular pertussis vaccines in Korea
por: Park, Chulmin, et al.
Publicado: (2019)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
por: Ausiello, Clara Maria, et al.
Publicado: (2014)

Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases
por: Van den Steen, Peter, et al.
Publicado: (2023)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
por: Markey, Kevin, et al.
Publicado: (2019)

Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV
por: Nunes, Marta C., et al.
Publicado: (2023)

Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens
por: Mi, Kai, et al.
Publicado: (2017)

Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice
por: Holubová, Jana, et al.
Publicado: (2020)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
por: Esposito, Susanna, et al.
Publicado: (2019)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
por: Knuutila, Aapo, et al.
Publicado: (2023)

Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model
por: Kang, Kyu Ri, et al.
Publicado: (2021)

Acellular Pertussis Vaccine Components: Today and Tomorrow
por: Dewan, Kalyan K., et al.
Publicado: (2020)

Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
por: Hara, Megumi, et al.
Publicado: (2015)

Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aP(gen) or combined TdaP(gen) vaccines
por: Pitisuttithum, Punnee, et al.
Publicado: (2021)

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
por: van Schuppen, Evi, et al.
Publicado: (2022)

Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia
por: Lam, Connie, et al.
Publicado: (2014)

Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines
por: Zomer, Aldert, et al.
Publicado: (2018)

Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
por: Abu-Raya, Bahaa, et al.
Publicado: (2018)

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
por: Decker, Michael D., et al.
Publicado: (2015)

Tetanus–diphtheria–acellular pertussis vaccination for adults: an update
por: Lee, Hyo-Jin, et al.
Publicado: (2017)

Proteomics of Bordetella pertussis whole-cell and acellular vaccines
por: Möller, Jens, et al.
Publicado: (2019)

Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy
por: Alghounaim, Mohammad, et al.
Publicado: (2022)

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults
por: Sirivichayakul, Chukiat, et al.
Publicado: (2016)

Increased Population Prevalence of Low Pertussis Toxin Antibody Levels in Young Children Preceding a Record Pertussis Epidemic in Australia
por: Campbell, Patricia, et al.
Publicado: (2012)

Half-life Estimation of Pertussis-Specific Maternal Antibodies in (Pre)Term Infants After In-Pregnancy Tetanus, Diphtheria, Acellular Pertussis Vaccination
por: Embacher, Stefan, et al.
Publicado: (2023)

Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose
por: Halperin, Scott A, et al.
Publicado: (2018)

Influence of Population Demography and Immunization History on the Impact of an Antenatal Pertussis Program
por: Campbell, Patricia Therese, et al.
Publicado: (2016)

Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis
por: Boehm, Dylan T., et al.
Publicado: (2019)

The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies
por: Abu-Raya, Bahaa, et al.
Publicado: (2019)

Erratum to: Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
Publicado: (2021)

Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice
por: Wolf, M. Allison, et al.
Publicado: (2021)

Maternal acellular pertussis vaccination in mice impairs cellular immunity to Bordetella pertussis infection in offspring
por: Dubois, Violaine, et al.
Publicado: (2023)

Tetanus, Diphtheria, and Acellular Pertussis and Influenza Vaccinations among Women With a Live Birth, Internet Panel Survey, 2017-2018
por: Murthy, Neil Chandra, et al.
Publicado: (2020)

Oral Diazepam in Febrile Seizures Following Acellular Pertussis Vaccination
por: Ghazavi, Mohammadreza, et al.
Publicado: (2019)

Global Childhood Deaths From Pertussis: A Historical Review
por: Chow, Maria Yui Kwan, et al.
Publicado: (2016)

1089 Safety and Immunogenicity of DTaP-IPV (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliovirus Vaccine) Compared to DAPTACEL(®) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) + IPOL(®) (Poliovirus Vaccine Inactivated) as the 5th Dose in Children 4 to 6 Years of Age
por: Smith, Michael, et al.
Publicado: (2014)

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine
por: Peterson, James T, et al.
Publicado: (2021)

Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage
por: Dubois, Violaine, et al.
Publicado: (2021)

Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019
por: Tessier, Elise, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qrj97o8l9tpipuq6sr0kohbv1g